| OTC Markets: BNVIQ
Bionovo, Inc. is a clinical drug discovery and development company, which is focused on developing drugs for the treatment of unmet medical needs in women's health and cancer. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Its lead drug candidate, Menerba (MF101) is designed to reduce the frequency and severity of menopausal hot flashes. Its Bezielle drug candidate is an oral anticancer agent for advanced breast cancer. The company was founded by Isaac Cohen and Mary Tagliaferri in February 2002 and is headquartered in Emeryville, CA.